Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: KEYS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on KEYS, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 374,565 KEYS shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 374,565 shares
    Change vs previous 13F -4,299 shares

    2.4% of the 13F portfolio, value $131,123,970.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 378,864 shares
    Change vs previous 13F -42,600 shares

    2.06% of the 13F portfolio, value $106,979,828.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 421,464 shares
    Change vs previous 13F -28,990 shares

    1.8% of the 13F portfolio, value $85,643,691.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 450,454 shares
    Change vs previous 13F -277,482 shares

    1.77% of the 13F portfolio, value $78,799,358.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 727,936 shares
    Change vs previous 13F -207,554 shares

    3.7% of the 13F portfolio, value $119,288,693.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 935,490 shares
    Change vs previous 13F +309,345 shares

    4.39% of the 13F portfolio, value $140,119,579.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 626,145 shares
    Change vs previous 13F +462,403 shares

    3.5% of the 13F portfolio, value $100,585,794.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 163,742 shares
    Change vs previous 13F not available

    0.9% of the 13F portfolio, value $26,025,392.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).